Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02188745
Title ER Reactivation Therapy for Breast Cancer (POLLY)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Dartmouth-Hitchcock Medical Center
Indications

Her2-receptor negative breast cancer

Therapies

Exemestane

Estradiol

Anastrozole

Letrozole

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.